Bank of Montreal
LAB icon

Bank of Montreal’s Standard BioTools LAB Stock Holding History

Bank of Montreal’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-43,400
Closed -$1.46M – 4098
2014
Q4 		$1.46M Hold
43,400
– – ﹤0.01% 1532
2014
Q3 		$1.06M Buy
+43,400
New +$1.22M ﹤0.01% 1742

Other funds holding LAB

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of Montreal's LAB Position: Q3 2024 in Review

Bank of Montreal sold out of Standard BioTools (LAB) in Q3 2024, closing a stake of 41,903 shares — an estimated $74.2K sold.

Bank of Montreal first reported a position in LAB in Q2 2013 and held it in 21 quarters. The position peaked at $342K in Q4 2014. 141 funds tracked by Wall St. Rank hold LAB as of Q3 2024.

  • Bank of Montreal reported no remaining Standard BioTools position as of Q3 2024 after selling out during the quarter.
  • Bank of Montreal sold 41,903 Standard BioTools shares in Q3 2024, an estimated $74.2K.
  • Bank of Montreal first reported a position in Standard BioTools in Q2 2013 and held it in 21 quarters.
  • Bank of Montreal's Standard BioTools position peaked at $342K in Q4 2014.
  • 141 funds tracked by Wall St. Rank held Standard BioTools as of Q3 2024.

Based on Bank of Montreal's 13F filing for Q3 2024, filed 13 Nov 2024.